OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Structure is Worth a Thousand Words: New Insights for RAS and RAF Regulation
Dhirendra K. Simanshu, Deborah K. Morrison
Cancer Discovery (2022) Vol. 12, Iss. 4, pp. 899-912
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Consensus on the RAS dimerization hypothesis: Strong evidence for lipid-mediated clustering but not for G-domain-mediated interactions
Dhirendra K. Simanshu, Mark R. Philips, John F. Hancock
Molecular Cell (2023) Vol. 83, Iss. 8, pp. 1210-1215
Open Access | Times Cited: 38

Structure of the SHOC2–MRAS–PP1C complex provides insights into RAF activation and Noonan syndrome
Daniel A. Bonsor, Patrick Alexander, Kelly Snead, et al.
Nature Structural & Molecular Biology (2022) Vol. 29, Iss. 10, pp. 966-977
Open Access | Times Cited: 37

Challenges and Opportunities in the Crusade of BRAF Inhibitors: From 2002 to 2022
Ankit Kumar Singh, Pankaj Sonawane, Adarsh Kumar, et al.
ACS Omega (2023) Vol. 8, Iss. 31, pp. 27819-27844
Open Access | Times Cited: 19

Reduced dynamic complexity allows structure elucidation of an excited state of KRASG13D
Fa-An Chao, Albert H. Chan, Srisathiyanarayanan Dharmaiah, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 14

Development of Personalized Strategies for Precisely Battling Malignant Melanoma
Armond J. Isaak, G Clements, Rand Gabriel M. Buenaventura, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 5023-5023
Open Access | Times Cited: 5

Identification of an H-Ras nanocluster disrupting peptide
Candy Laura Steffen, Ganesh babu Manoharan, Karolina Pavic, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 5

Targeting CRAF kinase in anti-cancer therapy: progress and opportunities
Penglei Wang, Kyle Vaughn Laster, Xuechao Jia, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 11

Functional and structural insights into RAS effector proteins
Alessandro M. Mozzarelli, Dhirendra K. Simanshu, Pau Castel
Molecular Cell (2024) Vol. 84, Iss. 15, pp. 2807-2821
Closed Access | Times Cited: 4

Ras S89D mutation induced allosteric changes that promoted its nucleotide exchange and signaling activation
Y Li, Wenxin Huang, Lu Guo, et al.
International Journal of Biological Macromolecules (2025) Vol. 294, pp. 139538-139538
Closed Access

Structural insights, regulation, and recent advances of RAS inhibitors in the MAPK signaling cascade: a medicinal chemistry perspective
Vimal H. Prajapati, Ankit Kumar Singh, Adarsh Kumar, et al.
RSC Medicinal Chemistry (2025)
Closed Access

Targeting RAS and associated proteins
Matthias Müller, Roger S. Goody, Daniel Rauh
Elsevier eBooks (2025)
Closed Access

Design, Synthesis, and Antitumor Activity of Stapled Peptide Inhibitors Targeting the RAS–RAF Interactions
Dan Han, Yu Zhou, Kai Zhang, et al.
European Journal of Medicinal Chemistry (2025), pp. 117568-117568
Closed Access

Molecular Dynamics Investigation into the Stability of KRas and CRaf Multimeric Complexes
Chao Geng, Juan Zeng, Xianming Deng, et al.
The Journal of Physical Chemistry B (2025)
Closed Access

In Silico Identification of Putative Allosteric Pockets and Inhibitors for the KRASG13D-SOS1 Complex in Cancer Therapy
Zehra Sarica, Özge Kürkçüoğlu, Fethiye Aylin Sungur
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3293-3293
Open Access

Regulation of RAF family kinases: new insights from recent structural and biochemical studies
Russell Spencer-Smith, Deborah K. Morrison
Biochemical Society Transactions (2024) Vol. 52, Iss. 3, pp. 1061-1069
Open Access | Times Cited: 3

Design, Synthesis, and Pharmacological Evaluation of Multisubstituted Pyrido[4,3-d]pyrimidine Analogues Bearing Deuterated Methylene Linkers as Potent KRASG12D Inhibitors
Xuanzheng Xiao, Juanjuan Feng, Jing Ma, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 22, pp. 15524-15549
Closed Access | Times Cited: 7

Cryo-EM Structures of CRAF2/14-3-32 and CRAF2/14-3-32/MEK12 Complexes
Dirk Dedden, Julius Nitsche, Elisabeth V. Schneider, et al.
Journal of Molecular Biology (2024) Vol. 436, Iss. 6, pp. 168483-168483
Closed Access | Times Cited: 2

Multiplexed, multimodal profiling of the intracellular activity, interactions, and druggability of protein variants using LABEL-seq
Jessica J. Simon, Douglas M. Fowler, Dustin J. Maly
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2

The Next Generation of KRAS Targeting: Reasons for Excitement and Concern
Neal S. Akhave, Amadeo B. Biter, David S. Hong
Molecular Cancer Therapeutics (2022) Vol. 21, Iss. 11, pp. 1645-1651
Open Access | Times Cited: 9

Oncogenic signaling pathways in pancreatic ductal adenocarcinoma
Rahul Agrawal, Kedar Nath Natarajan
Advances in cancer research (2023), pp. 251-283
Closed Access | Times Cited: 5

Glucocorticoid receptor and RAS: an unexpected couple in cancer
Ion Cristian Cirstea, Herwig P. Moll, Jan Tuckermann
Trends in Cell Biology (2022) Vol. 33, Iss. 7, pp. 594-604
Closed Access | Times Cited: 8

New insights into RAS in head and neck cancer
Sankar Jagadeeshan, Ofra Novoplansky, Oded Cohen, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188963-188963
Closed Access | Times Cited: 4

Unveiling the domain-specific and RAS isoform-specific details of BRAF kinase regulation
Tarah Elizabeth Trebino, Borna Markusic, Haihan Nan, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 4

Disruption of the pro-oncogenic c-RAF–PDE8A complex represents a differentiated approach to treating KRAS–c-RAF dependent PDAC
Sean F. Cooke, Thomas A. Wright, Yuan Yan Sin, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top